CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.
about
A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunityOestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Gene delivery with viral vectors for cerebrovascular diseases.Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.LIF in the regulation of T-cell fate and as a potential therapeutic.Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt?Role of leukemia inhibitory factor in the nervous system and its pathology.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.Oncostatin M protects against demyelination by inducing a protective microglial phenotype.iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.Stem cell therapy versus T lymphocytes: friend or foe?
P2860
Q27319470-DAEFF461-71CC-4704-AB61-4F11DED61492Q30479247-6B844A2F-AC17-486B-BA5E-ECD4AFAF849DQ33917592-1BFA38D8-57A0-4D2B-A0E1-9185FCA31787Q36580701-31F38865-499C-4583-8C9B-671626813C61Q37849132-774F6D06-80C0-4FEB-94D7-25A1117A8FC2Q37991400-B8B69F41-D63B-4F1C-BC36-28DDAF37134FQ38423423-64F38877-F51B-42F7-A7A5-62638647AE94Q40617937-4C162E2D-DD48-4713-BD7A-AB8B6819CEE0Q42131323-B89F4022-E1BA-47E1-B2F8-03698AA5AC94Q42145329-7FE0704A-AE39-4E0F-8C06-94A647564FCCQ45824204-A250E65C-D12A-44BA-9110-C6F03C915209Q45869813-21384E18-719C-4799-817F-EB46E0452775Q48490621-2301BBB4-5603-493B-B8FE-0EF7C6A3C80C
P2860
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CNS-targeted LIF expression im ...... a model of multiple sclerosis.
@en
type
label
CNS-targeted LIF expression im ...... a model of multiple sclerosis.
@en
prefLabel
CNS-targeted LIF expression im ...... a model of multiple sclerosis.
@en
P2093
P2860
P356
P1433
P1476
CNS-targeted LIF expression im ...... a model of multiple sclerosis.
@en
P2093
Chris Van den Haute
Helena Slaets
Jerome J A Hendriks
Niels Hellings
Piet Stinissen
P2860
P304
P356
10.1038/MT.2009.311
P577
2010-01-12T00:00:00Z